Health Condition 1: E119- Type 2 diabetes mellitus without complications
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Patients who fulfill case definition will be considered 2.Both sexes male and female 3.Patients of age group 45 to 65 years. 4.Patients with known case of diabetes mellitus who are on conventional anti-diabetic treatment with HBA1C >6.5%. 5.BSL fasting >126 mg/dl ; postprandial >200mg/dl
Exclusion criteria
Exclusion criteria: 1.Patients suffering from life threatening diseases and those who need emergency medical interventions. 2.Patients with any severe concomitant illness like Polyneuropathy, Cardio-vascular diseases, Retinopathy, nephropathy, kidney failure, Diabetic Ketoacidosis, who may not be able to come for regular follow -ups, will not be considered. 3.Any patient with gross neurological-neuropathy defects. 4.Patients with any major systemic illness.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Assessment of Cephalendra indica Q and Gymnema sylvestre Q on blood sugar level in type 2 diabetes mellitus.Timepoint: 1. Haematological examination (fasting blood sugar and postpranidial and HBA1C) will be done in every 15 days to assess and compare effect of homoeopathic mother tinctures in DMT2 patients in duration of 3 months 2. Symptomatic changes | — |
Secondary
| Measure | Time frame |
|---|---|
| â?¢ To know possible effective of Cephalendra indica Q in DMT2 patients. â?¢ To know possible effective of Gymnema sylvestre Q in DMT2 patients. â?¢ To control blood sugar levels and HBA1C levels to prevent complications of diabetes mellitus Timepoint: 1. Haematological examination (fasting blood sugar and postpranidial and HBA1C) will be done in every 15 days to assess and compare effect of homoeopathic mother tinctures in DMT2 patients in duration of 3 months 2. Symptomatic changes | — |
Countries
India
Contacts
B.V.D.U.Homoeopathic Medical College and Hospital, Dept of Post Graduate and Research Centre